The Effect of Obesity Hypoventilation Syndrome on Exercise Capacity, Peripheral Muscle Strength, and Quality of Life in Obese Individuals
1 other identifier
observational
64
1 country
1
Brief Summary
Obesity Hypoventilation Syndrome(OHS) is a disease characterized by daytime hypercapnia and sleep-disordered breathing without other causes of hypoventilation in individuals with a body mass index above 30 kg/m2. Sources state that obesity is at the basis of the metabolic changes seen in individuals with OHS. Obesity, together with cardiovascular system complications, lung volumes, work of breathing and sleep quality, creating the basis for respiratory problems. In addition, sedentary lifestyle habits, which are common in obese individuals, cause negative effects on exercise capacity and peripheral muscle strength. It has been shown in the literature that decreased exercise capacity due to obesity strongly interacts with the risk of all-cause mortality. As a result of obesity and all this negative picture, impaired emotional state and decreased quality of life are observed in individuals. Numerous studies have shown that obese individuals generally have a low level of physical activity, there is a decrease in peripheral muscle strength, obese individuals are at risk for sleep-related respiratory problems and health-related quality of life is often negatively affected in obese individuals. With these studies, the effects of obesity on individuals have been evaluated with objective evaluation methods. However, the same cannot be said for OHS. It is not clear how exercise capacity, peripheral muscle strength and quality of life parameters, which are known to be negatively affected by obesity, are affected in individuals with OHS. Based on this point, this study aims to investigate whether OHS has an additional effect on exercise capacity, peripheral muscle strength and quality of life in addition to obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 11, 2023
CompletedFirst Posted
Study publicly available on registry
November 21, 2023
CompletedStudy Start
First participant enrolled
April 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedOctober 2, 2025
September 1, 2025
9 months
November 11, 2023
September 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Six Minute Walk Test-Distance
The distance covered in meters in a straight corridor of 30 meters will be recorded as fast as possible but without running for 6 minutes.
1 day
Six Minute Walk Test-Oxygen Saturation
The 6-minute walk test is performed by walking as fast as possible for 6 minutes in a 30-meter corridor. Oxygen saturation measured by pulse oximetry before and after the test is recorded as a percentage.
1 day
Six Minute Walk Test-Heart Rate
The 6-minute walk test is performed by walking as fast as possible for 6 minutes in a 30-meter corridor. The heart rate measured by pulse oximetry is recorded before and after the test.
1 day
Six Minute Walk Test-Blood Pressure
The 6-minute walk test is performed by walking as fast as possible for 6 minutes in a 30-meter corridor. Before and after the test, blood pressure is measured with a sphygmomanometer and recorded in mmHg.
1 day
Six Minute Walk Test-Dyspnea
The 6-minute walk test is performed by walking as fast as possible for 6 minutes in a 30-meter corridor. Before and after the test, a score of 0-10 is recorded according to the Borg scale.
1 day
Six Minute Walk Test-Leg Fatigue
6 dakika yürüme testi, kişinin 30 metrelik bir koridorda 6 dakika boyunca mümkün olabilecek en hızlı şekilde yürümesi ile gerçekleştirilmektedir. Test öncesi ve sonrasında Borg skalasına göre 0-10 arasında puanlandırılarak kaydedilir.
1 day
Nottingham Health Profile
The Nottingham Health Profile (NHP) is a general patient reported outcome measure which seeks to measure subjective health status. It is a questionnaire designed to measure a patient's view of their own health status, in a number of areas. The NHP consists of two parts. The first part focuses on health and comprises 38 items which deal with pain, energy, sleep, mobility, emotional reaction and social isolation. The second part focuses on life areas affected and consists of 7 items which deal with problems regarding occupation, housework, social life, family life, sexual function, hobbies and holidays. The second part of the NHP is optional and can be omitted without ruining the test results.
1 day
Muscle Strength - Dynamometer
A digital dynamometer will be used to evaluate muscle strength. Muscle strength will be evaluated in the following muscles, each measurement will be made three times and the average will be taken.
1 day
Secondary Outcomes (11)
Body Fat Percentage
1 day
Body Fluid Percentage
1 day
Muscle Mass
1 day
Body Mass Index
1 day
Anthropometric Measurements-Neck
1 day
- +6 more secondary outcomes
Study Arms (2)
Grup I
Subjects with obesity hypoventilation syndrome (30 \< body mass index \< 45 kg/m2)
Grup II
Age and sex-matched obese subjects (30 \< body mass index \< 45 kg/m2) with low risk of obstructive sleep apnea (STOP-BANG score \< 3)
Interventions
Between December 2023 and June 204, 46 volunteer participants aged 18 years and older who met the inclusion criteria and were followed up at Istanbul University, Istanbul Faculty of Medicine, Department of Chest Diseases and Istanbul Faculty of Medicine, Department of Internal Medicine were included in the project. Participants' body composition, comorbidities, exercise capacity, peripheral muscle strength, sleep quality and quality of life were assessed.
Eligibility Criteria
Patients with Obesity Hypoventilation Syndrome who are followed up in Istanbul University, Istanbul Faculty of Medicine, Department of Chest Diseases and obese individuals who are followed up in Istanbul University, Istanbul Faculty of Medicine, Department of Internal Diseases and who are in the low risk group according to stop bang evaluation will be included in the study.
You may qualify if:
- \< body mass index \< 45 kg/m2
- Patients who have been diagnosed with Obesity Hypoventilation Syndrome
- Obese subjects with low risk of obstructive sleep apnea (STOP-BANG score \< 3)
You may not qualify if:
- Patients with uncontrollable respiratory and comorbid diseases
- Patient who have been an orthopedic, neurological, cardiac, or metabolic condition that may prevent participation and continuation of the exercise program throughout the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Istanbul Universitylead
- Istanbul University - Cerrahpasacollaborator
Study Sites (1)
Istanbul University-Cerrahpasa
Istanbul, 34320, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Goksen KURAN ASLAN, Assoc. Prof.
Istanbul University - Cerrahpasa
- STUDY CHAIR
Ece ACIKBAS, PT,MSc
Istanbul University - Cerrahpasa
- STUDY CHAIR
Ozge ERTAN HARPUTLU, PT,MSc
Istanbul University - Cerrahpasa
- STUDY CHAIR
Esen KIYAN, Prof
Istanbul University
- STUDY CHAIR
Bedia Fulya CALIKOGLU, Lect. PhD
Istanbul University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associated Proffesor
Study Record Dates
First Submitted
November 11, 2023
First Posted
November 21, 2023
Study Start
April 10, 2024
Primary Completion
January 1, 2025
Study Completion
March 1, 2025
Last Updated
October 2, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share